Latest News
August 30, 2016
Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests
January 13, 2015
Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital
September 17, 2014
Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument
January 8, 2014
Spinomix announces a milestone payment from Debiopharm Group™ and the appointment of a new CEO